CLINICAL USEFULNESS OF BACILLINUM

TO VERIFY CLINICAL UTILITY OF UNEXPLORED ASPECTS OF BACILLINUM

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052579

Enrollment

Registered

2023-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: BACILLINUM: medicine will be given in a singe dose or requiement of case ,every week or requirment of case by oral route. Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: the cases which needs constitutional remedy.(eg, F/h of tuberculosis) in the case when well chosen remedy failed to act the case which have paucity of symptoms Patients under 5 to 75 years of age.

Exclusion criteria

Exclusion criteria: the cases with congenital anomaly. patients under 5 years and more than 75 years and pragnant women.

Design outcomes

Primary

Measure	Time frame
MYMOP SCORETimepoint: EVERY WEEK OR AS PER REQUIREMENT OF CASE .	—

Secondary

Measure	Time frame
MYMOP SCORETimepoint: EVERY WEEK OR AS PER REQUIREMENT OF CASE .	—

Countries

India

Contacts

Public ContactUTTARA JAGDISHCHANDRA SHAH

Dr V H Dave Homoeopathic Medical College

dr.sonal2705@gmail.com9426432585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026